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A B S T R A C T
Rationale and objective: The burden of breast cancer has increased worldwide. Breast cancer mortality has
been increasing in Central and South America (CSA) in the last few decades. We describe the current
burden of breast cancer in CSA and review the current status of disease control.
Methods: We obtained regional- and national-level incidence data from 48 population-based cancer
registries in 13 countries and cancer deaths from the WHO mortality database for 18 countries. We
estimated world population age-standardized incidence and mortality rates per 100,000 person-years
for 2003–2007 and the estimated annual percentage change to describe time trends.
Results: In the most recent 5-year period, Argentina, Brazil, and Uruguay had the highest incidence rates
(67.7–71.9) and Bolivia and El Salvador had the lowest (7.9–12.7). For most countries, mortality rates were
12.3, except in Uruguay, Argentina and Cuba (14.9-20.5). Age-speciﬁc rates increased after the age of
40–50 years and reached a maximum after age 65 years (mean age at diagnosis 56–62 years). Most
countries have developed national screening guidelines; however, there is limited capacity for screening.
Conclusion: The geographic variation of breast cancer rates may be explained by differences in the
prevalence of reproductive patterns, lifestyle factors, early detection, and healthcare access. Extending
early-detection programs is challenging because of inequalities in healthcare access and coverage,
limited funding, and inadequate infrastructure, and thus it may not be feasible. Given the current status
of breast cancer in CSA, data generated by population-based cancer registries is urgently needed for
effective planning for cancer control.
ã 2015 International Agency for Research on Cancer; Licensee Elsevier Ltd. This is an open access article
under the CC BY-NC-ND IGO 3.0 license (https://creativecommons.org/licenses/by-nc-nd/3.0/igo/).
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Breast cancer is the most common cancer diagnosed among
women worldwide and the leading cause of cancer death, with
approximately 1.67 million new cancer cases and more than half a
million cancer-related deaths estimated to have occurred in 2012.
There are marked geographical differences in the incidence and
mortality of breast cancer across the world, with the highest age-
standardized rates observed in the more developed regions (all$ This is an Open Access article published under the CC BY NC ND 3.0 IGO license
which permits users to download and share the article for non-commercial
purposes, so long as the article is reproduced in the whole without changes, and
provided the original source is properly cited. This article shall not be used or
reproduced in association with the promotion of commercial products, services or
any entity. There should be no suggestion that IARC endorses any speciﬁc
organisation, products or services. The use of the IARC logo is not permitted. This
notice should be preserved along with the article’s original URL.
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creativecommons.org/licenses/by-nc-nd/3.0/igo/).regions of Europe, North America, Australia/New Zealand and
Japan) and the lowest rates in less developed regions (all regions of
Africa, Asia excluding Japan, Latin America and the Caribbean,
Melanesia, Micronesia and Polynesia), with incidences of 74.1 and
31.3 per 100,000, and mortality of 14.9 and 11.5 per 100,000,
respectively [1].
The incidence of breast cancer has rapidly increased in most
high-income countries, but mortality rates have decreased in the
past 3 decades. In contrast, rapid increases in breast cancer
incidence and mortality rates have been described in countries
undergoing rapid changes in human development, probably a
result of increases in risk factors associated with economic
development and urbanization (i.e. obesity and physical inactivi-
ty), changes in reproductive patterns, earlier age at menarche,
shorter duration of breastfeeding, as well as increased detection
through mammography and healthcare access [2].
The Central and South American (CSA) region has undergone an
epidemiological and demographic transition brought about by
rapid economic growth, and it is now experiencing a high burden
of breast cancer [3–5]. In 2012, breast cancer was the common. This is an open access article under the CC BY-NC-ND IGO 3.0 license (https://
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females, with over 140,000 new breast cancer diagnoses and
nearly 40,000 cancer deaths occurring in CSA [1]. Several reports
indicate that the incidence and (mainly) mortality rates of breast
cancer are increasing [6–11]. By 2030, the burden of female breast
cancer in CSA is estimated to increase by 70% (224,000 new cases
and 66,000 deaths) due to demographic changes [1]. Given the
expected increase in female breast cancer in the CSA region, it is
crucial to provide an updated description of the incidence and
mortality patterns, particularly because incidence statistics from
many CSA countries are lacking. We present a description of
incidence and mortality patterns in the CSA region and provide an
overview of early-detection programs and strategies to promote
women's breast health in CSA, as well as an overview of the
epidemiology of breast cancer in the region, in order to explain the
geographic variations in cancer rates.
2. Methods
The present analysis includes female breast cancer (C50) as
coded by the 10th edition of the International Classiﬁcation of
Diseases for Oncology (ICD-10). The data sources and methods are
described in detail in an earlier article in this supplement issue. In
brief, we obtained regional- and national-level incidence data from
48 population-based cancer registries in 13 countries and
nationwide cancer deaths from the World Health Organization
mortality database for 18 countries. We estimated age-standard-
ized incidence and mortality rates per 100,000 person-years using
the direct method and the world standard population [12,13]. We
estimated national age-standardized incidence rates by aggregat-
ing the data from the available cancer registries using a weighted
average of local rates. To describe incidence and mortality time
trends, we calculated the estimated annual percentage change
(EAPC) for the most recent 10-year period using the method
proposed by Esteve et al. [14]. Trends in incidence and mortality
and EAPCs were estimated for four countries (Table 1). All of the
EAPCs were tested for equality to zero by using the corresponding
standard errors. We considered EAPCs statistically signiﬁcant if the
P-value  0.05. We conducted the data analysis in Stata1 version
12.1 (StataCorp) [15].
Information on early detection and breast cancer screening in
CSA was obtained from the Pan American Health Organization
(PAHO) non-communicable diseases (NCDs) country capacity
survey of 2013 [16] and complemented with information from
scientiﬁc papers published in peer-reviewed journals.
3. Results
3.1. Breast cancer incidence and mortality patterns
Breast cancer was the most frequent cancer diagnosis among
females in the CSA region, except in Bolivia and El Salvador. The
highest age-standardized incidence rates were in Argentina, Brazil,
and Uruguay (between 67.7 and 71.9) and the lowest in Bolivia
(12.7) and El Salvador (7.9). Breast cancer was one of the two
leading causes of cancer death among females in most CSATable 1
Countries included in the analysis of time trends.
Country Name of registries included 
Argentina Bahia Blanca 
Brazil Aracaju, Fortaleza, Goiania, Sao Paulo 
Chile Valdivia 
Costa Rica National registry countries, with the exceptions of Ecuador, Peru, Nicaragua, and
Guatemala. The highest age-standardized mortality rates were in
Uruguay (20.5), Argentina (19.4) and Cuba (14.9), and the lowest
were in Guatemala (3.9) and El Salvador (4.1) (Table 2).
The age-speciﬁc incidence pattern for breast cancer was similar
across countries; rates were relatively low before the age of
40 years. In general, age-speciﬁc rates increased sharply after the
age of 40–50 years and reached a maximum after the age of
65 years, except in El Salvador and Mexico where the incidence
slope seems to be ﬂat after the age of 50 years. Age-speciﬁc
mortality rates followed a similar pattern as incidence rates, with
the highest rates observed in older age groups (Fig. 1).
Trends in breast cancer incidence tended to increase in Brazil
(1997–2006), Chile (1997–2008), and Costa Rica (1985–2007),
whereas in Argentina (1998–2007) rates appear to have declined in
more recent years. Mortality rates in the four countries were stable
or seemed to decline during the corresponding years of observa-
tion. However, there was no statistically signiﬁcant change in
incidence or mortality rates over the last 10-year period in these
four countries. EAPCs ranged from 1.8 to 2.5 for incidence and
from 1.0 to 0.4 for mortality (Figs. 2 and 3).
3.2. Early detection and mammography screening
Mammography screening among 50–69-year-old women is
effective in reducing breast cancer mortality [17]; breast cancer
mortality can be reduced by 25% in women 50–69 years old [18].
Clinical breast examination (CBE), an inexpensive technique, has
been suggested as an alternative to mammography as it can detect
60% of the cancers that otherwise would be detected by
mammography [19]. CBE shifts the stage distribution of tumors
detected toward an earlier stage (down-staging); however, there is
inadequate evidence to conclude that CBE reduced breast cancer
mortality [17].
As of 2009, the following countries have developed a legislative
framework for the early detection, diagnosis, treatment and
follow-up of breast cancer: Argentina (introduced in 2000,
changed in 2003), Brazil (2004, 2008), Bolivia (2004), Chile
(1995, 2001, 2007), Colombia (2000), Costa Rica (1988, 1994, 2000,
2002), Ecuador (2006, 2007), Mexico (2004), Panama (2007), Peru
(2008), and Uruguay (1991, 2000, 2005) [11,20–24].
According to the PAHO NCDs country capacity survey of 2013
[16], most countries in the CSA region have national recommen-
dations for breast cancer screening, with the exception of Ecuador
where the guidelines are currently under development. The
guidelines included mammography screening combined with
CBE, and in some countries breast self-exam (BSE) as well. In
general, annual or biennial mammography was recommended for
all women 50–70 years of age, except in Panama where the
baseline mammography screening begins in women at age
35 years, and in Costa Rica, Colombia, Peru and Uruguay where
screening starts at age 40 years. Women with a family history of
breast cancer (high-risk women), mammography screening was
recommended every year starting at age 35 or 40 years [25].
Mammography screening in the public sector was generally
available in ten countries, whereas in the private sectorPeriod % of the population covered
1993–2007 0.8
1997–2006 8.0
1993–2008 2.2
1985–2007 100.0
Table 2
Age-standardized incidence and mortality rates (per 100,000) from female breast cancer, all ages.
Incidence Mortality
Country Period Cases Crude
Rate
ASR (W) MV (%) Ranka Deaths Crude
Rate
ASR (W) Ranka
CENTRAL AMERICA
Belize 2003–07 – – – – – 39 5.5 9.3 2
Costa Rica 1985–89 1266 18.3 26.9 94 1 571 8.2 11.6 4
2003–07 3845 36.6 39.7 95 1 1147 10.8 11.5 1
Cubab 2004–07 780 48.4 32.4 94 1 4947 22.1 14.9 2
El Salvador 1999–03 918 6.4 7.9 96 3 512 3.3 4.1 2
Guatemala 2003–07 – – – – – 805 2.5 3.9 5
Mexicob 2006–10 5819 32.9 35.6 100 1 23583 7.9 9.9 2
Nicaragua 2003–07 – – – – – 497 3.6 5.5 4
Panama 2003–07 – – – – – 668 8.3 9.0 1
SOUTH AMERICA
Argentinab 2003–07 10494 81.3 71.9 84 1 26768 27.1 19.4 1
Boliviab 2011 161 11.9 12.7 96 2 – – – –
Brazilb 2003–07 42458 68.9 70.2 89 1 51222 10.9 11.0 1
Chileb 2003–07 847 38.0 35.0 93 1 5603 13.6 10.9 2
Colombiab 2003–07 4505 44.8 43.3 96 1 9584 8.8 10.0 2
Ecuadorb 2003–07 1576 30.6 34.4 94 1 1718 5.1 6.1 3
French Guyanab 2003–08 187 37.3 47.8 97 1 – – – –
Paraguay 2003–07 – – – – – 1204 8.3 11.1 2
Perub 2001–05 3262 34.0 35.1 87 1 3305 4.9 6.0 3
Suriname 2003–07 – – – – – 115 9.3 9.7 2
Uruguay 2005–07 5055 98.3 67.7 90 1 1799 34.9 20.5 1
Venezuela 2003–07 – – – – – 6998 10.6 12.3 2
ASR, age standardized (world population) rate per 100,000; MV, microscopic veriﬁcation.
a Rank within the country based on highest ASR excluding: All sites but C44 and All sites.
b Incidence rates were estimated using aggregated data from regional cancer registries.
S112 A. Di Sibio et al. / Cancer Epidemiology 44S (2016) S110–S120mammography was available in most countries (except Cuba,
Guyana, Paraguay, and Peru). Trained staff were available to
perform mammography in 14 countries. CBE was available in both
the public and private sectors in all countries (except in the private
sector in Cuba) and trained staff were generally available to
perform the procedure (Table 3).
BSE was recommended for women after the age of 20 years in
Mexico, Peru, Panama and Peru. In El Salvador monthly BSE was
recommended for all women after menarche, and CBE was
recommended for all women during any contact with a healthcare
worker. Only Bolivia recommended BSE for women 25–64 years as
the sole early detection method [25]. In Cuba, BSE is recommended
along with an annual checkup for women 30 years [26].
Mammography screening coverage was 46% in Argentina for
women aged 50–70 years in 2005 (deﬁned as the percentage of
women who had a mammogram within the last 2 years), 32% in
Chile among women aged 50 years (public sector, 2006–2008), 54%
in Colombia (2009), 2.3% in Cuba for women aged 50–64 years
(2013), 22% in Mexico for women aged 40–69 years (2006), and
30% in Peru for women aged 40 years. In Costa Rica, 34% of the
women 40 years old responding to a national survey in
2006 reported ever having had a mammogram [26–28]. CBE data
coverage was generally not reported, except in Colombia, where it
was 34% in 2009 [25].
Community-speciﬁc projects for early detection of breast
cancer are conducted in Brazil, Colombia, Mexico and Peru. Brazil
implemented a government-organized mammography screening
program among women 40–69 years old using mobile and ﬁxed
screening units in the Barretos region, São Paulo, and 19 adjacent
municipalities. From 2003 to 2005 almost 18,000 women were
screened, covering 33% of the target population; 76 women had
breast cancer (detection rate 4.2 per 1000), 43% were detected in
the early stages, and 16% were detected at advanced stages [29]. In
2010 more than 3.1 million women received a mammography
screening in the public health system in 2010, reaching a national
coverage of 26.5% for women 40–49 years old (even though it is notrecommended in this age group), 32% for 50–59 years old, 25% for
60–69 years old and 10.1% for 70 years old. Mammography
coverage varied by region, ranging from 9.5% in the North to 39.4%
in the South for women 40–49 years old, and from 3.5% in the
North to 14.4% in the South for women 70 years old. More than
17,000 women with abnormal ﬁndings underwent biopsy,
13,020 breast cancer cases were detected and 17,598 women
underwent surgeries for invasive breast cancer; the frequency of
biopsies and surgeries varied by age and region [30].
In 2008, Colombia began a pilot project in Bogota to evaluate
approaches to opportunistic screening, including impact of the
national screening guidelines on breast cancer down-staging and
opportunistic screening with mammography and CBE, and to
estimate the costs for implementing such programs in the
healthcare system [31]. A survey among 1106 women with breast
cancer showed that >80% of the women went to the doctor because
of symptoms, and the majority had advanced-stage disease; 20% of
the patients experienced delays (time elapsed from ﬁrst symptoms
to initial consultation) due to older age, lack of social security,
advanced clinical stage, and lower education level. Delays for
diagnosis and treatment were about 3 and 5 months, respectively.
Women of higher socioeconomic status and those with health
insurance programs supporting employees and their families were
more likely to have screening-detected breast cancers and faster
breast cancer diagnosis and treatment than women with subsi-
dized healthcare plans for low-income populations, special
healthcare plans for teachers and military personnel, and those
with no healthcare plans [32–34].
In Mexico, the ﬁrst mammography screening program con-
ducted in Mexico City using mobile screening units in local
communities examined nearly 97,000 women (>40 years) in 2005–
2006 and revealed that 1% of the mammograms were abnormal
(n = 949); 79% of the women who had an abnormal mammogram
underwent further examinations, among them 208 breast cancer
cases were detected (29% in stage I and 42% in stage II), giving a
detection rate of 2.1 per 1000 [35].
.
00
1
.
01
.
1
1
10
10
0
10
00
5 15 25 35 45 55 65 75+
Incidence
.
00
1
.
01
.
1
1
10
10
0
10
00
5 15 25 35 45 55 65 75+
Mortality
R
at
es
 (lo
g s
ca
le)
 pe
r 1
00
,00
0 p
ers
on
-ye
ars
Central America
Belize Costa Rica Cuba* El Salvador Guatemala
Mexico* Nicaragua Panama
.
00
1
.
01
.
1
1
10
10
0
10
00
5 15 25 35 45 55 65 75+
Incidence
.
00
1
.
01
.
1
1
10
10
0
10
00
5 15 25 35 45 55 65 75+
Mortality
R
at
es
 (lo
g s
ca
le)
 pe
r 1
00
,00
0 p
ers
on
-ye
ars
South America
Argentina* Bolivia* Brazil* Chile* Colombia*
Ecuador* French Guyana Peru* Uruguay* Venezuela
*Incidence rates were estimated using aggregated data from regional cancer registries
Fig. 1. Age-speciﬁc incidence and mortality rates (per 100,000) for female breast cancer in Central and South America.
A. Di Sibio et al. / Cancer Epidemiology 44S (2016) S110–S120 S113Peru has launched the breast cancer awareness campaign “A las
mujeres no nos gana el cáncer de mama” in panels and television
advertisements; the campaigns seem to have had a major impact in
urban areas because the information is disseminated on local andregional radio, with culturally appropriate messages to remote
populations. Health professionals have received training on the
national guidelines [36]. In 2012, a pilot project was launched in
Northern Peru to improve breast cancer screening and diagnostic
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Fig. 2. Trends in female breast cancer incidence and mortality, all ages.
S114 A. Di Sibio et al. / Cancer Epidemiology 44S (2016) S110–S120services in remote areas; it involves the training of community
health workers in breast health promotion, providers in CBE, and
doctors in ﬁne-needle aspiration (FNA) biopsy. Women who have-1.8
-6 -4 -2 
Argentina
1
 (1998-2007)
Brazil
1
 (1997-2006)
Costa Rica (1997-2007)
Chile
1
 (1997-2008)
*The estimated annual per
1 Incidence rates were
Fig. 3. Estimated annual percentage change in age-standardized incidsuspicious masses are referred for further examinations and
diagnostic FNA biopsies at a local hospital, and those with
conﬁrmed cancers undergo treatment at a regional cancer center
in northern Peru [37,38].
4. Discussion
Breast cancer was the most common cancer diagnosed and one
of the leading cause of cancer death in females in most CSA
countries. In general, there was a wide variation in breast cancer
incidence and mortality rates across the region. The highest rates
in Central America were almost 50% lower than the highest rates
observed in South America. The incidence of breast cancer seen in
Argentina, Brazil, and Uruguay (67.7–71.9) reached incidence levels
similar to those of other countries of very high economic
development, such as the United States (overall 89.2 and 66.8 in
Hispanics) and Canada (77.7) [39].
Uruguay had one of the highest breast cancer mortality rates in
the world in 2003–2007, only surpassed by Barbados (23.9) and
Denmark (21.6). Argentina also experienced remarkably high
mortality rates, ranking 11th in the world; these rates were
comparable to the mortality rates in the United Kingdom, Israel,
Hungary, New Zealand and Malta (rates in the range 19.1–19.8)
[40]. Cuba had the highest mortality in Central America, rates
which were similar to those in countries of high or very high
economic development. In contrast, Guatemala and El Salvador
had the lowest breast cancer mortality rates in the world, followed
by Peru, Ecuador, and Nicaragua. Rates in these countries were
similar to those in Egypt (5.6) and the Republic of Korea (4.9) [40].
The geographic variation observed in breast cancer rates could
be explained by differences in registration practices and under-
ascertainment as well as changes in the prevalence of factors
known to increase the risk of this disease such as early menarche,-0.9
0.4
-0.7
0.2
1.7
-1.0
2.5
0 2 4 6
cent change is statistically different from zero (p<=.05)
 estimated using data from regional cancer registries
MortalityIncidence
ence and mortality rates (per 100,000) for female breast cancer.
Table 3
General availability of tests and procedures for breast cancer screening at the primary healthcare level [16].
General availability
Public sector Private Sector Trained staff available
Clinical breast
examination
Argentina, Belize, Bolivia, Brazil, Chile, Colombia,
Costa Rica, Cuba, Ecuador, El Salvador,
Guatemala, Guyana,a Honduras, Mexico,
Nicaragua, Panama, Paraguay, Suriname,
Uruguay, Venezuela
Argentina, Belize, Bolivia, Brazil, Chile, Colombia,
Costa Rica, Ecuador, El Salvador, Guatemala,
Honduras, Mexico, Nicaragua, Panama,
Paraguay, Suriname, Uruguay, Venezuela
Argentina, Belize, Bolivia, Brazil, Chile, Colombia,
Costa Rica, Cuba, Ecuador, El Salvador,
Guatemala, Honduras, Mexico, Nicaragua,
Panama, Paraguay, Suriname, Uruguay,
Venezuela
Mammogram Argentina, Brazil, Chile, Colombia, Cuba, Mexico,
Nicaragua, Suriname, Uruguay, Venezuela
Argentina, Belize, Bolivia, Brazil, Chile, Colombia,
Costa Rica, Ecuador, El Salvador, Guatemala,
Honduras, Mexico, Nicaragua, Panama,
Suriname, Uruguay, Venezuela
Argentina, Bolivia, Brazil, Chile, Colombia, Costa
Rica, Cuba, Guatemala, Honduras, Mexico,
Nicaragua, Suriname, Uruguay, Venezuela
Note: no data for French Guyana.
a Source: [25].
A. Di Sibio et al. / Cancer Epidemiology 44S (2016) S110–S120 S115late age at ﬁrst pregnancy, low number of pregnancies, short or no
periods of breastfeeding, a later menopause, estrogen–progesto-
gen oral contraceptives (OCs) or HRT use, obesity (for postmeno-
pausal breast cancer only), alcohol consumption, and physical
inactivity [2,41–49].
We did not detect statistically signiﬁcant changes in breast
cancer incidence or mortality rates over the last 10-year period in
Argentina, Brazil, Chile and Costa Rica. However, incidence rates
tended to increase (except in Argentina) and mortality rates tended
to remain stable or declined in recent years. Likewise, no
statistically signiﬁcant changes in the incidence of breast cancer
have been reported in Brazil and Colombia (Pasto) over the past
decades [2,50]. In contrast, increases in incidence rates have been
reported in Costa Rica, Colombia (Cali), Ecuador (Quito) and
Panama [2,9,51]. Mortality rates have increased in Colombia, Brazil
(2001–2012), Ecuador, Guatemala, and Mexico since the 1980s and
Panama since 2000, whereas in Costa Rica, Chile, and Uruguay
mortality rates have decreased and in Argentina (Cordoba), Belize,
Cuba, Nicaragua, Paraguay and Venezuela rates have remained
constant in the last few decades [2,4,6,11,51–57]. Some of the
discrepancies observed across studies maybe explained by the
differences in the periods evaluated and may also reﬂect changes in
the prevalence of factors associated with this disease, together
with differences in early detection and healthcare access
[5,11,22,23,27,56,58–64].
We observed a similar age-speciﬁc pattern in the incidence of
breast cancer as the pattern described for some European and
North American countries, with a marked increase around
menopause and a slow increase thereafter, which seems to be
due to diminishing levels of circulating estrogens [65]. We also
detected a different age-speciﬁc pattern in El Salvador and Mexico
(ﬂattened slope after menopause); similar patterns after meno-
pause and even negative slopes have been described in low-risk
countries (e.g. Khon Kaen, Taiwan) which is probably a result of a
cohort effect, i.e., increasing risk of disease in consecutive
generations rather than a genuine age-related decline in risk. [65].
In many low- and middle-income countries, a relatively high
proportion of breast cancers seem to be diagnosed in younger
women, which has led to the assumption that breast cancer occurs
more frequently at a younger age; however, this seems to be driven
by the structure of the population rather than by higher age-
speciﬁc incidence rates in younger women [18,65,66]. In fact, the
observed mean age at breast cancer diagnosis across CSA countries
was between 56 and 62 years.
4.1. Determinants of breast cancer in CSA
4.1.1. Reproductive and hormonal factors
Early age at menarche has been associated with a Western diet
and physical inactivity and increased body mass index (BMI) [67].Declines in age at menarche have been reported in transitioning
countries over the past few decades [68], including Argentina [69],
Brazil [70,71], Chile [72,73], Colombia [74] and Ecuador [75], which
have been linked to improved living conditions and expanded
access to health services.
In CSA, fertility rates (number of births per woman) have been
declining since the 1960s, which coincides with the increased
burden of breast cancer [5,76]. In Argentina, Brazil and Uruguay we
observed the highest incidence rates of breast cancer, and these
countries also had some of the lowest fertility rates in the region
(on average about two children per woman, similar to the fertility
rate in the United States). In contrast, breast cancer mortality rates
in Guatemala, Nicaragua, Peru, and Ecuador were among the
lowest in the region and fertility rates were among the highest
(range about three to four children per woman) [77]. It has been
reported that changes in childbearing patterns (fewer children and
delayed age at births) over the past decades could probably affect
the burden of breast cancer incidence in the future [46,47].
Breastfeeding reduces the risk of developing breast cancer by
39% (ever versus never), and the effect is stronger with longer
duration [48]. Research from Brazil, Colombia, Peru and Mexico is
consistent with these ﬁndings [78,79]. The increase in breast
cancer incidence in Mexico is thought to be related to the decline in
the prevalence of breastfeeding in young women (no breastfeeding
or shortened duration) due to women's lifestyle changes combined
with the low fertility rates [79]. Increases in breastfeeding duration
have been reported in Bolivia, Brazil, Colombia, Nicaragua and Peru
over the last 2 decades due to changing behaviors within the
population [80]. In 2010, the prevalence of breastfeeding in most
CSA countries was higher than that in the United States (30–72%
versus 19%, respectively), except in Paraguay (24%), Belize (19%),
Mexico (15%) and Suriname (3%) [77].
Combined estrogen–progestogen contraceptives (OCs) and
combined estrogen–progestagen menopausal therapy are causa-
tive factors for breast cancer [81]. Two different meta-analyses
have shown that the risk of breast cancer increases 7.6% per every
year increase in use of estrogen–progesterone therapy [82], and
that current hormonal replacement therapy (HRT) use increases
the risk of in-situ and invasive ductal breast cancers by 51% and
67%, respectively, as compared to never users [83]. Although little
is known about OC and HRT use in the CSA region, a recent matched
case–control study conducted in approximately 2000 Mexican
women 35–69 years old (CAMA) revealed that ever HRT users had a
45% higher risk of developing postmenopausal breast cancer as
compared to never users; no associations were found with OC use
[84].
4.1.2. Lifestyle-related factors
Overweight and obesity have been consistently associated with
an increased risk of breast carcinoma, and the relationship differs
S116 A. Di Sibio et al. / Cancer Epidemiology 44S (2016) S110–S120by pre- and postmenopausal status and by tumor hormone-
receptor status [85–88]. Recent estimates revealed that 12% of all
the postmenopausal breast cancer cases estimated to occur in Latin
America in 2012 were attributable to overweight and obesity
(BMI  25 kg/m2) [89]. In 2010, 50–60% of the population in CSA
were overweight (BMI  25 kg/m2) and 20–30% were obese
(BMI > 30 kg/m2), except in Mexico, Suriname, Panama, and Chile
where >60% of the population were overweight and >30% were
obese [77]. It is estimated that by the year 2030, approximately 60%
of women in the region will be overweight or obese, and in Cuba
and Panama about 90% of the population is estimated to be
overweight or obese [90]. The rising obesity epidemic in CSA [90–
92] suggests that overweight/obesity could potentially have a large
impact on the total breast cancer burden in the future.
Physical inactivity (insufﬁcient physical activity to meet current
recommendations) increases the risk of breast cancer by 33% [93].
In Latin America, 14% of all the breast cancer cases estimated to
occur in 2008 were due to physical inactivity: 19.4% in Argentina,
14.1–14.9% in Ecuador, Colombia and Brazil, 11.6–12.5 in Uruguay,
Paraguay, and Mexico, and 5.5% in Guatemala [93]. A case–control
study among low-income women in Brazil revealed that women
who had a sedentary lifestyle had 2.4 times higher risk of
developing malignant breast diseases than controls; the associa-
tion remained the same after further adjustment for hormone-
related factors, family history of breast cancer and percentage of
body fat [94]. In contrast, physical activity (all forms, recreational
or occupational) probably protects against postmenopausal breast
cancer but the evidence is limited for premenopausal breast cancer
[60,95]; the risk of breast cancer among active women is 10–39%
lower than those who were least active [96,97]. The CAMA study
revealed that for every 3 h per week of moderate to intense
physical activity the risk of breast cancer was 4% lower in
premenopausal and 10% lower in postmenopausal women than in
less active women [98]. The CAMA study also showed that women
who had a very healthy lifestyle had a 50% lower risk of developing
premenopausal breast cancer and an 80% lower risk of postmeno-
pausal breast cancer when compared to women with less healthy
lifestyles [99].
Consumption of alcoholic beverages is a well-established cause
of female breast cancer [81]. The risk of breast cancer increases by
32% and 46% for consumption of 35–44 g and 45 g of alcohol per
day, respectively, as compared to non-drinkers. The risk of breast
cancer increased by 7.1% per each additional one drink (10 g of
alcohol) of alcohol intake per day regardless of smoking status, and
it differed by menopausal status [85]. The CAMA study showed that
Mexican women who reported ever drinking alcohol had a 25%
higher risk of breast cancer than never drinkers; the effect was
stronger if women had lower folate levels [100]. Drinking patterns
among women in the region may explain some of the geographic
variation in breast cancer rates. For instance, in Brazil, the per
capita consumption of alcohol has increased by 8.9% over the past
25 years (difference between 4.7 g/day per capita in 1980 and
13.6 g/day per capita in 2005), which translates into an increase in
the incidence of female breast cancer of 7.5%, assuming that the
increased drinking pattern was maintained in the population [68].
4.1.3. Other factors
In spite of the high relative risk of inherited mutations in high-
penetrance susceptibility genes [101–103], family or personal
history of breast cancer [42] and exposure to ionizing radiation
[43] account for a small percentage of breast cancer cases
diagnosed in the general population given their low prevalence.
Tamoxifen is an established factor known to reduce the risk of
contralateral breast cancer of breast cancer patients [81]; however,
given cost considerations, its widespread use in CSA is limited
[5,8,37].4.2. Early detection and mammographic screening
It is possible that the geographic variation in incidence rates
reﬂect early detection efforts and screening activities. However, the
lack of long-term incidence data for most CSA countries precludes an
evaluation as to whether rates have been increasing after such
activitiesbegan. InCostaRica, forexample,breast cancer incidence in
2003–2007 was50% higher when comparedtothe rates from 1985to
1989 (26.9 versus 39.7, respectively) while mortality rates were very
similar (11.6 versus 11.5); such a stark increase in incidence from the
two periods could be a reﬂection of early detection efforts
implemented since 1988, whereas mortality rates may additionally
reﬂect access to and quality of healthcare [23,27]. In Chile incidence
rates sharply increased after 1995 until the early 2000s, whereas
mortality rates stayed stable and tended to decline in recent years
(although not statistically signiﬁcantly) which could be a reﬂection
of the early detection efforts established since 1995. Prieto et al. [22]
showed that the distribution of breast cancer cases presented at the
public health system in Chile have down-staged from 1999 to 2003,
which may reﬂect the impact of early detection activities in this
country.
Given the recent actions for early detection and screening
implemented in several CSA countries, it is expected that the
incidence of breast cancer will increase in the near future due to
the detection of previously undiagnosed disease. Even considering
that mammography is offered cost-free in countries where it is
available (except in Paraguay and Peru) [4,104,105], the current
mammography screening rates in CSA are below the WHO
recommendations of 70% coverage in order to achieve reductions
in breast cancer mortality [37]. Our review indicated that in some
areas screening was extended to women 40–49 years of age in spite
of their respective country's recommendation; thus those pro-
grams could be further improved by following the appropriate age
limits. Several community-speciﬁc projects for early detection of
breast cancer were initiated in Brazil, Colombia, Mexico and Peru,
some of which are focusing on the evaluation of CBE. Extending
screening coverage requires access to proper tissue diagnosis and
treatment for women with breast cancer since a cost-effective
program must have adequate follow-up [18]. In countries where
resources are limited and women are diagnosed at late stages,
mammography screening may not be feasible; hence, the
relevance of down-staging palpable tumors [37,106]. BSE and
CBE are important screening measures in low- and middle-income
countries to detect palpable tumors at the earliest stage [106].
Moreover, disparities in healthcare access, low coverage, lack of
personnel, and inadequate infrastructure and funding, as well as
socioeconomic and cultural barriers, prevent women from seeking
timely breast cancer care which in turn affects breast cancer
outcomes [21,28,32,35,37,58,107–117].
5. Strengths and limitations
This study has several strengths and limitations. We present a
comprehensive analysis of the current burden of breast cancer in
CSA, including incidence data for 13 countries (48 cancer
registries) and mortality data for 18 countries. However, data
patterns should be interpreted with caution because countrywide
incidence rates are represented by aggregated data from regional
cancer registries which do not cover the entire country, with the
exception of the national cancer registries of Costa Rica and
Uruguay. Registrations may also differ in completeness and data
quality, which could explain the low breast cancer incidence rates
observed in Bolivia and El Salvador. The percentage of microscopi-
cally veriﬁed (MV) cases, a quality indicator of cancer registry data,
in most CSA countries was higher than the estimated mean MV%
A. Di Sibio et al. / Cancer Epidemiology 44S (2016) S110–S120 S117for breast cancer for cancer registries in the region (95.0% Central
America and the Caribbean, 82.3% in South America and 83.6% in
Brazil) which raises some questions about the validity of the data
(Table 2) [118]. Consequently establishing and promoting cancer
registration in CSA is crucial for cancer control planning. Moreover,
evaluation of early-detection programs will beneﬁt from the
systematic collection of data pertaining to clinical stage at
diagnosis which is lacking in most registries.
6. Conclusion
Breast cancer is the most common female cancer diagnosis
and one of the leading causes of cancer-related deaths among
women in most CSA countries. Explaining the remarkable
geographic variations in breast cancer rates is complex because
of the interrelated effects of known and presumed factors
associated with this disease, combined with the effects of early
detection and healthcare access, and limited cancer registry data.
The elevated incidence rates observed in Argentina, Brazil and
Uruguay are similar to incidence levels in countries of higher
economic development. Uruguay and Argentina had some of the
highest breast cancer mortality rates in the world, whereas
Guatemala and Nicaragua had the lowest rates in the world. These
results emphasize the need to increase support for cancer
registration in CSA to produce data to better understand the
reasons for these disparities and to improve planning for cancer
control.
Given the demographic and epidemiological change brought
by the continued economic growth, many lifestyle factors are
changing in CSA. These changes, accompanied by lack of public
awareness and limited capacity for screening and healthcare
access, suggest that the future burden of breast cancer is likely to
increase beyond the increase which has already been projected,
unless resource-dependent actions are taken. In response to the
increasing burden of breast cancer, most CSA countries have
developed national screening guidelines and some have a
legislative framework for breast cancer control. The current
mammography screening coverage is below the WHO recom-
mendations to achieve a reduction in overall breast cancer
mortality. Hence, Brazil, Colombia, and Mexico have initiated
screening projects, particularly in remote areas. Peru is testing a
community-based model to promote breast cancer awareness
and CBE screening in rural women. The widespread use of early-
detection programs in CSA is challenging and in some areas may
not be feasible because of disparities in healthcare access, low
coverage, lack of personnel, and inadequate infrastructure and
funding. Socioeconomic and cultural barriers prevent women
from seeking timely breast cancer care, which further highlights
the need for resource-dependent actions for breast cancer
control.
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